HQY250117C110000
- 0.15
- +0.10+200.00%
HealthEquity Newsroom
RBC Capital Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $105
RBC Capital Sticks to Its Buy Rating for Healthequity (HQY)
Those Who Invested in HealthEquity (NASDAQ:HQY) Three Years Ago Are up 97%
Here's Why HealthEquity (HQY) Traded Lower in Q3
HealthEquity Gains 46.8% in a Year: What's Driving the Stock?
PACS or HQY: Which Is the Better Value Stock Right Now?
HealthEquity, Inc.'s (NASDAQ:HQY) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
J.P. Morgan's Top Healthcare Stocks for 2025
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
HealthEquity Caps 2024 With Widespread Recognition For Its Workplace Excellence
Healthequity Insider Sold Shares Worth $477,800, According to a Recent SEC Filing
Healthequity's Strong Performance and Promising Outlook Justifies Buy Rating
BofA Securities Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $120
Leadership Change at Healthequity Inc.: Challenges and Risks as Scott Cutler Steps In as CEO
Are Investors Undervaluing HealthEquity, Inc. (NASDAQ:HQY) By 42%?
Health Equity Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results.
Barrington Maintains HealthEquity(HQY.US) With Buy Rating, Cuts Target Price to $112
HealthEquity Price Target Raised to $107.00/Share From $105.00 by JMP Securities
Barrington Research Cuts HealthEquity Price Target to $112 From $120, Maintains Outperform Rating
HealthEquity Is Maintained at Outperform by RBC Capital